Tendering for off-patent outpatient medicines: lessons learned from experiences in Belgium, Denmark and the Netherlands-Reference-Cited by-同舟云学术

Tendering for off-patent outpatient medicines: lessons learned from experiences in Belgium, Denmark and the Netherlands

Published:2017-05-31 Issue:3 Volume:8 Page:147-158
ISSN:1759-8885
Container-title:Journal of Pharmaceutical Health Services Research
language:en
Short-container-title:J Pharm Health Serv Res

Author:

Vogler Sabine¹^ORCID,Gombocz Margit¹,Zimmermann Nina¹

Affiliation:

1. Pharmacoeconomics Department; WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies; Gesundheit Österreich GmbH (GÖG/Austrian Public Health Institute); Vienna Austria

Funder

Main Association of Austrian Social Insurance Institutions

Publisher

Oxford University Press (OUP)

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jphs.12180/fullpdf

Reference63 articles.

1. GPhA report: savings: $1 trillion over 10 years - generic drug savings in the U.S;Health;J Pharm Health Serv Res,2012

2. The contribution of generic substitution to rationalizing pharmaceutical expenditure in Greek public hospitals under recent economic crisis;Kontodimopoulos;J Pharm Health Serv Res,2013

3. Overcoming challenges in market access of generic medicines in the European Union;Dylst;J Gen Med,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between Multimorbidity and Out-of-Pocket Expenditures for Prescription Medicines among Adults in Denmark: A Population-Based Register Study;2023-11-22

2. A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply;Frontiers in Medicine;2023-10-30

3. Überblick über Maßnahmen zur Förderung des Einsatzes von Biosimilars in europäischen Ländern;Arzneiverordnungs-Report 2023;2023

4. Competitive tenders on analogue hospital pharmaceuticals in Denmark 2017–2020;Journal of Pharmaceutical Policy and Practice;2022-10-22

5. The analogue substitution model: Introducing competition in the absence of generic substitution in Danish hospitals;Health Policy;2022-09